CD274 and neoplasm: On the other hand, the combination of immune checkpoint inhibitors (ICIs), such as PD-1/PD-L1 inhibitors, with ferroptosis inducers has been shown to significantly enhance therapeutic efficacy, particularly in ferroptosis-sensitive tumor cells (46).